13F filer · CIK 923093 ↗
Tudor Investment
You are looking at Q1 2016. See the latest, Q2 2026 →
Reported value
$3.91B
First quarter on file
Positions
1,691
First quarter on file
Top 10
28.3%
of the value
Est. gain
—
Nothing to compare
Est. return
—
Nothing to compare
Positions as of Mar 31, 2016, from Tudor Investment's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
The 24 largest positions, 39% of the reported value, each sized by its share. Striped tiles are options.
SPDR S&P 500 ETF TrustPUT13%
SPDR S&P 500 ETF TrustCALL5.3%
Ishares Msci Emerging Markets - ETFCALL2.8%
Starwood Hotels & Resorts1.2%
Bard (C.R.) Incorporated1.2%
Zimmer Biomet Holdings Inc1.1%
SPDR S&P 500 ETF Trust1.1%
Time Warner Cable1.0%
Fidelity National Information Services1.0%
Ipath S&P 500 Vix Short-Term Futures EtnPUT1.0%
Transunion1.0%
Merck & Co. Incorporated1.0%
Allergan PlcPUT1.0%
Wal-Mart Stores Incorporated0.9%
Ishares Msci Emerging Markets - ETF0.8%
Laboratory Corp. Of America Holdings0.8%
Alphabet0.8%Medivation Inc0.8%
Total System Services Inc.0.8%
SPDR Barclays High Yield Bond ETF0.7%
Allergan Plc0.7%
Emc Corporation0.7%
Pepsico Incorporated0.7%
Heartland Payment Systems Inc0.6%
Holdings
As of Mar 31, 2016. This is the first quarter on file, so nothing is compared yet.
| Holding | Value | |||||
|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustPUTCOMMON STOCK | 12.5% | $490.4M | ||||
| SPDR S&P 500 ETF TrustCALLCOMMON STOCK | 5.3% | $208.9M | ||||
| Ishares Msci Emerging Markets - ETFCALLCOMMON STOCK | 2.8% | $111.3M | ||||
| Starwood Hotels & ResortsCOMMON STOCK | 1.2% | $45.9M | ||||
| Bard (C.R.) IncorporatedCOMMON STOCK | 1.2% | $45.8M | ||||
| Zimmer Biomet Holdings IncCOMMON STOCK | 1.1% | $42.3M | ||||
| SPDR S&P 500 ETF TrustCOMMON STOCK | 1.1% | $41.7M | ||||
| Time Warner CableCOMMON STOCK | 1.0% | $40.9M | ||||
| Fidelity National Information ServicesCOMMON STOCK | 1.0% | $40.9M | ||||
| Ipath S&P 500 Vix Short-Term Futures EtnPUTCOMMON STOCK | 1.0% | $39.6M | ||||
| TransunionCOMMON STOCK | 0.98% | $38.1M | ||||
| Merck & Co. IncorporatedCOMMON STOCK | 0.97% | $37.8M | ||||
| Allergan PlcPUTCOMMON STOCK | 0.96% | $37.5M | ||||
| Wal-Mart Stores IncorporatedCOMMON STOCK | 0.92% | $36.0M | ||||
| Ishares Msci Emerging Markets - ETFCOMMON STOCK | 0.79% | $30.8M | ||||
| Laboratory Corp. Of America HoldingsCOMMON STOCK | 0.78% | $30.7M | ||||
| AlphabetCOMMON STOCK | 0.78% | $30.6M | ||||
| Medivation IncCOMMON STOCK | 0.78% | $30.4M | ||||
| Total System Services Inc.COMMON STOCK | 0.75% | $29.5M | ||||
| SPDR Barclays High Yield Bond ETFCALLCOMMON STOCK | 0.70% | $27.4M | ||||
| Allergan PlcCOMMON STOCK | 0.69% | $26.9M | ||||
| Emc CorporationCOMMON STOCK | 0.67% | $26.0M | ||||
| Pepsico IncorporatedCOMMON STOCK | 0.66% | $25.8M | ||||
| Heartland Payment Systems IncCOMMON STOCK | 0.63% | $24.8M | ||||
| Graphic Packaging Holding CoCOMMON STOCK | 0.63% | $24.5M | ||||
| Total · 1,691 positions | 100% | $3.91B |
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $71.91B+33% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $53.87B−0% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $54.03B−7% | SEC ↗ |
| Q3 2025 | Dec 9, 2025 (amended) | $57.98B+26% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $45.92B+53% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $30.10B+15% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $26.28B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.48B+41% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $19.52B+24% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $15.72B+27% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $12.42B+25% | SEC ↗ |
| Q3 2023 | Nov 15, 2023 | $9.97B+19% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $8.38B+30% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $6.46B+28% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $5.06B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $4.63B+22% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.81B−11% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $4.27B−29% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $5.98B−3% | SEC ↗ |
| Q3 2021 | Nov 17, 2021 (amended) | $6.16B+16% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $5.29B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $4.99B+41% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $3.54B+54% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $2.30B+14% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $2.02B+81% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $1.12B−50% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $2.23B−23% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $2.91B−17% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $3.51B+45% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $2.42B−52% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $5.06B+27% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $3.98B+38% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $2.87B−7% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $3.09B−22% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $3.94B+0% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $3.92B+19% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $3.28B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $3.25B−16% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $3.88B−9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $4.27B−10% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $4.72B+21% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $3.91B | SEC ↗ |